Skip to main content
SpringerLink
Log in

Pseudobulbair affect bij multiple sclerose

  • Published:
Tijdschrift voor Neuropsychiatrie en Gedragsneurologie

Samenvatting

Dwanglachen en dwanghuilen (pseudobulbair affect) worden veel gezien bij MS-patiënten. Er is dan sprake van een ontkoppeling tussen de ervaring en de uiting van emoties, of van een verlies aan controle over deze uiting. De patiënten kunnen plotseling uitbarsten in een ongecontroleerd, onwillekeurig en onbeheersbaar lachen of – vaker – huilen, zonder dat ze op dat moment de emoties hoeven te ervaren die daarbij horen. Ziektebesef en ziekte-inzicht zijn meestal grotendeels intact. De emotionele uitbarstingen worden daarom ervaren als ego-dystoon en de patiënten kunnen erg lijden onder hun emotionele incontinentie. Ze kunnen erdoor in verlegenheid worden gebracht en zullen proberen om het dwanglachen of dwanghuilen onder controle te krijgen. Helaas lukt dat slechts ten dele, zodat afzondering en sociale isolatie vaak het gevolg zijn. Pseudobulbair affect bij MS wordt zelden onderzocht, onvoldoende gediagnosticeerd en daardoor te weinig behandeld. Er zijn echter meerdere effectieve behandelingen beschikbaar die opvallend snel resultaat kunnen geven.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literauur

  1. Parvizi J, Coburn KL, Shillcutt SD, et al. Neuroanatomy of pathological laughing and crying: A report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 2009;21:75–87.

    Article  PubMed  Google Scholar 

  2. Allman P. Crying and laughing after brain damage (letter). J Neurol Neurosurg Psychiatry 1990;53:1439–40.

    Google Scholar 

  3. Cummings JL, Arciniegas DB, Brooks BR, et al: Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 2006;11:1–7

    PubMed  Google Scholar 

  4. Altschuler EL, Wisdom S. An old case of pathological laughing and crying. Lancet 1999;354:1736.

    Article  CAS  PubMed  Google Scholar 

  5. Miller A. Pseudobulbar affect in multiple sclerosis: Toward the development of innovative therapeutic strategies. J Neurol Sci. 2006 Jun 15;245(1-2):153–9.

    Article  PubMed  Google Scholar 

  6. Work SS, Colamonico JA, Bradley WG, Kaye RE. Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther. 2011 Jul;28(7):586–601

    Article  PubMed  Google Scholar 

  7. Colamonico J, Formella A, Bradley W. Pseudobulbar affect: burden of illness in the USA. Adv Ther. 2012 Sep;29(9):775–98

    Article  PubMed  Google Scholar 

  8. Romano S, Nocentini U. Euphoria, pathological laughing and crying. In: Nocentini U, Caltagirone C, Tedeschi G. Neuropsychiatric dysfunction in multiple sclerosis. Milan: Springer, 2012.

    Google Scholar 

  9. Olney NT, Goodkind MS, Lomen-Hoerth C, Whalen PK, Williamson CA, Holley DE, Verstaen A, Brown LM, Miller BL, Kornak J, Levenson RW, Rosen HJ. Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis. Brain 2011;134:3458–69.

    Article  PubMed  Google Scholar 

  10. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry. 1993 Feb;150(2):286–93.

    CAS  PubMed  Google Scholar 

  11. Moore SR, Gresham LS, Bromberg MB, Kasarkis EJ, Smith RA. A self report measure of affective lability. J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):89–93.

    Article  CAS  PubMed  Google Scholar 

  12. Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN. The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci. 1999 Oct 31;169(1-2):22–5.

    Article  CAS  PubMed  Google Scholar 

  13. Smith RA, Berg JE, Pope LE, Callahan JD, Wynn D, Thisted RA. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult Scler. 2004 Dec;10(6):679–85.

    Article  PubMed  Google Scholar 

  14. NVN. Richtlijn Multiple Sclerose. Houten: Bohn Stafleu Van Loghum, 2013.

    Google Scholar 

  15. Iacovides A, Andreoulakis E. Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review. Curr Opin Psychiatry. 2011 Jul;24(4):336–40.

    Article  PubMed  Google Scholar 

  16. Arts K. Depressies bij multiple sclerose. Tijdschr Neuropsychiat Gedragsneurol 2013;1:12–21.

    Article  Google Scholar 

  17. Ghaffar O, Chamelian L, Feinstein A. Neuroanatomy of pseudobulbar affect; A quantitative MRI study in multiple sclerosis. J Neurol. 2008 Mar;255(3):406–12.

    Article  PubMed  Google Scholar 

  18. Finger S. A Happy State of Mind; A History of Mild Elation, Denial of Disability, Optimism, and Laughing in Multiple Sclerosis. Arch Neurol. 1998;55:241–250

    Article  CAS  PubMed  Google Scholar 

  19. Wilson SAK: Some problems in neurology. II: Pathological laughing and crying. J Neurol Psychopathol 1924;4:299–333. Reprinted in: Wilson SAK: Some problems in neurology. London: Arnold, 1928. Reprint: Nijmegen: Arts & Boeve, 1996.

    Google Scholar 

  20. Wortzel HS, Oster TJ, Anderson CA, Arciniegas DB. Pathological laughing and crying : epidemiology, pathophysiology and treatment. CNS Drugs. 2008;22(7):531–45.

    Article  CAS  PubMed  Google Scholar 

  21. Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A; Psuedobulbar Affect in Multiple Sclerosis Study Group. Randomized, Controlled Trial of Dextromethorphan/Quinidine for Pseudobulbar Affect in Multiple Sclerosis. Ann Neurol. 2006 May;59(5):780–7.

  22. Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, Hepner A, Kaye R; Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 2010 Nov;68(5):693–702.

    Article  CAS  PubMed  Google Scholar 

  23. European Medicines Agency (EMA). Nuedexta; Dextrometorphan and quinidine. Summary of opinion (initial authorization). 25 April 2013. EMA/CHMP/132029/2013.

  24. Miller A, Pratt H, Schiffer RB.Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Rev Neurother. 2011 Jul;11(7):1077–88.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pro Persona in Wolfheze, Renkum, The Netherlands

    Klaas Arts

Authors
  1. Klaas Arts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaas Arts.

Additional information

Drs. N.J.M. Arts, gedragsneuroloog, Winkler Kliniek, centrum voor neuropsychiatrie en gedragsneurologie van Pro Persona in Wolfheze en Thalamus, polikliniek voor neuropsychiatrie van Pro Persona in Wolfheze.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arts, K. Pseudobulbair affect bij multiple sclerose. Tijdsvoor Neuropsy en Gedragsneuro 1, 60–64 (2013). https://doi.org/10.1007/s40533-013-0012-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40533-013-0012-8

Search

Navigation